New Imaging Collaboration Could Improve Treatment and Quality of Life of Prostate Cancer Patients
|
By MedImaging International staff writers Posted on 27 Jul 2015 |
|
A development agreement between a large medical imaging vendor and smaller medical device company promises to help promote a unique minimally invasive treatment that can ablate the prostate gland.
The agreement will give the device developer access to a large installed base of Magnetic Resonance Imaging (MRI) systems, and customers. The new system can perform minimally invasive, whole gland ablation of the prostate gland in a single session with fewer side effects, and increased quality of life for patients, compared to existing treatments.
The agreement, between Royal Philips (Amsterdam, the Netherlands), and Profound Medical (Toronto, ON, Canada) will help Profound Medical continue to develop its proprietary Transurethral Ultrasound Ablation (TULSA) technology. The TULSA system is designed to work on Philips’ Ingenia and Achieva 3T MRI systems.
The agreement will help Philips continue to expand in the interventional oncology market, using real-time (MRI) 3-D visualization of soft tissue, and industry-leading MRI guided procedure solutions.
Steve Plymale, CEO, of Profound Medical, said, “Philips has stepped forward and enthusiastically shares our vision for the technology. With their support, TULSA-PRO will soon be available to clinicians and patients for primary treatment of localized prostate cancer. This new relationship will provide us with access to a large installed base of MRI systems and customers and we look forward to developing this mutually rewarding relationship further.”
Profound Medical is aiming to obtain the Conformité Européenne (CE) marking and market the TULSA-PRO system in 2016 in Europe and in Canada.
Related Links:
Philips Healthcare
Profound Medical
The agreement will give the device developer access to a large installed base of Magnetic Resonance Imaging (MRI) systems, and customers. The new system can perform minimally invasive, whole gland ablation of the prostate gland in a single session with fewer side effects, and increased quality of life for patients, compared to existing treatments.
The agreement, between Royal Philips (Amsterdam, the Netherlands), and Profound Medical (Toronto, ON, Canada) will help Profound Medical continue to develop its proprietary Transurethral Ultrasound Ablation (TULSA) technology. The TULSA system is designed to work on Philips’ Ingenia and Achieva 3T MRI systems.
The agreement will help Philips continue to expand in the interventional oncology market, using real-time (MRI) 3-D visualization of soft tissue, and industry-leading MRI guided procedure solutions.
Steve Plymale, CEO, of Profound Medical, said, “Philips has stepped forward and enthusiastically shares our vision for the technology. With their support, TULSA-PRO will soon be available to clinicians and patients for primary treatment of localized prostate cancer. This new relationship will provide us with access to a large installed base of MRI systems and customers and we look forward to developing this mutually rewarding relationship further.”
Profound Medical is aiming to obtain the Conformité Européenne (CE) marking and market the TULSA-PRO system in 2016 in Europe and in Canada.
Related Links:
Philips Healthcare
Profound Medical
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Color Doppler Ultrasound System
DRE Crystal 4PX
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Mobile Digital C-arm X-Ray System
HHMC-200D
Latest Nuclear Medicine News
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
Channels
Radiography
view channel
Novel Breast Imaging System Proves As Effective As Mammography
Breast cancer remains the most frequently diagnosed cancer among women. It is projected that one in eight women will be diagnosed with breast cancer during her lifetime, and one in 42 women who turn 50... Read more
AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
Radiologists typically detect one case of cancer for every 200 mammograms reviewed. However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing,... Read more
MRI
view channel
Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
Magnetic Resonance Imaging (MRI) has significantly transformed healthcare, providing a noninvasive, radiation-free method for detailed imaging. It is especially promising for the future of medical diagnosis... Read more
World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
The world's first whole-body ultra-high field (UHF) MRI has officially come to market, marking a remarkable advancement in diagnostic radiology. United Imaging (Shanghai, China) has secured clearance from the U.... Read more
Ultrasound
view channel.jpg "Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)")
Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease
Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more
Super-Resolution Imaging Technique Could Improve Evaluation of Cardiac Conditions
The heart depends on efficient blood circulation to pump blood throughout the body, delivering oxygen to tissues and removing carbon dioxide and waste. Yet, when heart vessels are damaged, it can disrupt... Read more
First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity
Ultrasound scans are essential for identifying and diagnosing various medical conditions, but often, patients must wait weeks or months for results due to a shortage of qualified medical professionals... Read more
General/Advanced Imaging
view channel
Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
One of the most significant challenges in oncology care is disease complexity in terms of the variety of cancer types and the individualized presentation of each patient. This complexity necessitates a... Read more
PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
A key challenge for clinicians treating patients with multiple sclerosis (MS) is that after a certain amount of time, they continue to worsen even though their MRIs show no change. A new study has now... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Hologic, Inc. (Marlborough, MA, USA) has entered into a definitive agreement to acquire Endomagnetics Ltd. (Cambridge, UK), a privately held developer of breast cancer surgery technologies, for approximately... Read more
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
